Ozempic and Alcohol — Can You Still Drink?

Join Dr. Ben Synth as he uncovers the unexpected connection between Ozempic and alcohol cravings that's baffling the medical world. This series explores the cutting-edge science behind why a diabetes medication is making people lose their desire to drink and whether weight loss drugs could revolutionize addiction treatment.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores how semaglutide (Ozempic) shows promise beyond weight loss—reducing alcohol cravings in both rodent studies and human trials published in JAMA Psychiatry. The episode examines emerging evidence that GLP-1 drugs may help treat alcohol use disorder and other addictions by modulating brain reward pathways, while addressing limitations, costs, and unanswered questions about long-term efficacy.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores what really happens when you mix alcohol with GLP-1 medications like Ozempic and Wegovy. From amplified nausea to hypoglycemia risks, he examines the science behind interactions the FDA label doesn't mention — and why millions navigating these drugs need better guidance before their next drink.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores how GLP-1 drugs like Ozempic and Wegovy—prescribed for diabetes and weight loss—are unexpectedly reducing alcohol cravings by modulating brain reward circuits. From rodent studies to clinical trials and patient reports, we examine the neuroscience behind why people are losing interest in drinking without willpower or withdrawal, and what this means for addiction treatment.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.